OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
LibPubMedia1@gmail.com
Aptamers
Open-access, peer-reviewed
The Eur J Extracellular Vesicles
Open-access, peer-reviewed

Silver Sponsor – Digital Stand

Pure Biologics  S.A. is one of the largest Polish biotech companies. Founded in 2010, it is listed on the NewConnect market of the Warsaw Stock Exchange.

Pure Biologics’ major R&D activity focuses on bispecific and fusion antibodies, as well as aptamers to be developed into viable candidates for therapeutics in immunooncology (colorectal, breast and lung cancers), and in the treatment of neurological diseases (neuromyelitis optica, myasthenia gravis).

To this end, Pure Biologics has created highly efficient platforms to generate specific antibodies and modified aptamers, supported by state-of-the-art assays and analytics. Moreover, Pure Biologics utilizes its broad experience in antibodies, aptamers, cell and molecular biology, protein and antigen expression and purification, custom assay development, and ligand-binding analysis, offering complex solutions not only as a contract research organization and service provider, but primarily as a professional consultant and R&D partner. Its customers represent a wide variety of environments, ranging from academic collaborations to pharma and biotech companies. Pure Biologics aims to out-license its early-stage assets and to connect with partners in need of complex biotechnological solutions.



Leaflets

Meet the Team

Ms Monika Czarnecka

Pure Biologics S.A.
ul. Duńska 11
54-427 Wrocław
Poland

 

Ms Magda Puchala

Pure Biologics S.A.
ul. Duńska 11
54-427 Wrocław
Poland

 

If you would like to book a meeting with these team members via a breakout room during break hours, please send your name and email address to AptamersOxford@gmail.com.

Breakout rooms are open to registered delegates only.


 

Download PDF Documents Password protected 

Important Deadlines

Early Registration: 17 Jul 2020
Standard Registration: 28 Aug 2020
Oral Abstracts: Closed
Poster Abstracts: 14 Aug 2020
Digital Posters: 28 Aug 2020

Join our emailing list
CAPTCHA
Please wait...